KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Shares Repurchased (2016 - 2025)

Historic Shares Repurchased for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $305.0 million.

  • Abbott Laboratories' Shares Repurchased fell 5938.75% to $305.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $906.0 million, marking a year-over-year decrease of 2687.65%. This contributed to the annual value of $1.3 billion for FY2024, which is 554.2% up from last year.
  • Per Abbott Laboratories' latest filing, its Shares Repurchased stood at $305.0 million for Q3 2025, which was down 5938.75% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Shares Repurchased registered a high of $2.3 billion during Q1 2022, and its lowest value of $2.0 million during Q3 2023.
  • Over the past 5 years, Abbott Laboratories' median Shares Repurchased value was $315.0 million (recorded in 2024), while the average stood at $484.6 million.
  • Its Shares Repurchased has fluctuated over the past 5 years, first crashed by 9974.94% in 2023, then soared by 3745000.0% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' Shares Repurchased stood at $974.0 million in 2021, then dropped by 29.67% to $685.0 million in 2022, then tumbled by 62.19% to $259.0 million in 2023, then grew by 21.62% to $315.0 million in 2024, then fell by 3.17% to $305.0 million in 2025.
  • Its last three reported values are $305.0 million in Q3 2025, $6.0 million for Q2 2025, and $280.0 million during Q1 2025.